Published in Pol Tyg Lek on October 18, 1976
A randomized clinical trial of high-intensity warfarin vs. conventional antithrombotic therapy for the prevention of recurrent thrombosis in patients with the antiphospholipid syndrome (WAPS). J Thromb Haemost (2005) 3.47
Classification and practical approach to the diagnosis and management of hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy (2013) 2.35
Relationship of inhibition of prostaglandin biosynthesis by analgesics to asthma attacks in aspirin-sensitive patients. Br Med J (1975) 2.29
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. J Allergy Clin Immunol (2012) 2.17
Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest (1998) 2.13
Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study. Allergy (2012) 2.12
Clinical patterns of hypersensitivity to nonsteroidal anti-inflammatory drugs and their pathogenesis. J Allergy Clin Immunol (1977) 1.88
Plasma 9alpha,11beta-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma. Thorax (2004) 1.80
Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis. J Thromb Haemost (2006) 1.61
Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation. Circulation (2001) 1.61
Successful therapy of advanced arteriosclerosis obliterans with prostacyclin. Lancet (1979) 1.57
Blood coagulation at the site of microvascular injury: effects of low-dose aspirin. Blood (2001) 1.54
EAACI/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity. Allergy (2007) 1.53
Humoral immunosuppression in men exposed to polycyclic aromatic hydrocarbons and related carcinogens in polluted environments. Environ Health Perspect (1994) 1.49
Prostaglandin E2 systemic production in patients with asthma with and without aspirin hypersensitivity. Thorax (2007) 1.48
More on: Fluvastatin inhibits upregulation of tissue factor expression by antiphospholipid antibodies on endothelial cells. J Thromb Haemost (2005) 1.46
A half of schoolchildren with 'ISAAC eczema' are ill with allergic contact dermatitis. J Eur Acad Dermatol Venereol (2010) 1.46
Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet (1997) 1.43
Inhibition of thrombin generation by aspirin. Thromb Haemost (1994) 1.40
Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs) - classification, diagnosis and management: review of the EAACI/ENDA(#) and GA2LEN/HANNA*. Allergy (2011) 1.30
Aspirin-tolerant asthmatics generate more lipoxins than aspirin-intolerant asthmatics. Eur Respir J (2000) 1.29
The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study. J Thromb Haemost (2009) 1.28
Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia. Int J Cardiol (2001) 1.25
Aspirin-induced asthma. Hypersensitivity to fenoprofen and ibuprofen in relation to their inhibitory action on prostaglandin generation by different microsomal enzymic preparations. J Allergy Clin Immunol (1976) 1.25
Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Am J Respir Crit Care Med (1998) 1.24
Asthma relieved by aspirin and by other cyclo-oxygenase inhibitors. Thorax (1978) 1.24
Enhanced expression of the leukotriene C(4) synthase due to overactive transcription of an allelic variant associated with aspirin-intolerant asthma. Am J Respir Cell Mol Biol (2000) 1.22
Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma. Eur Respir J (2000) 1.13
Classification of allergic and pseudoallergic reactions to drugs that inhibit cyclooxygenase enzymes. Ann Allergy Asthma Immunol (2001) 1.13
Cysteinyl leukotrienes overproduction and mast cell activation in aspirin-provoked bronchospasm in asthma. Eur Respir J (1993) 1.13
The effect of six prostaglandins, prostacyclin and iloprost on generation of superoxide anions by human polymorphonuclear leukocytes stimulated by zymosan or formyl-methionyl-leucyl-phenylalanine. Biochem Pharmacol (1987) 1.12
Prevalence of asthma with aspirin hypersensitivity in the adult population of Poland. Allergy (2003) 1.11
Haemodynamic changes induced by prostacyclin in man. Br Heart J (1980) 1.11
Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease. J Thromb Haemost (2006) 1.10
Important research questions in allergy and related diseases: 3-chronic rhinosinusitis and nasal polyposis - a GALEN study. Allergy (2009) 1.08
Autoimmune phenomena in bronchial asthma with special reference to aspirin intolerance. Am J Respir Crit Care Med (1995) 1.05
Eicosanoids in bronchoalveolar lavage fluid of aspirin-intolerant patients with asthma after aspirin challenge. Am J Respir Crit Care Med (1994) 1.05
Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma. J Allergy Clin Immunol (1998) 1.03
Polyandry increases offspring fecundity in the bulb mite. Evolution (2001) 1.02
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy (2007) 1.01
The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy (1996) 1.00
Aspirin-induced asthma and HLA-DRB1 and HLA-DPB1 genotypes. Clin Exp Allergy (1997) 1.00
Pl(A2) polymorphism of beta(3) integrins is associated with enhanced thrombin generation and impaired antithrombotic action of aspirin at the site of microvascular injury. Circulation (2001) 1.00
Bronchodilatory properties of 2-decarboxy-2-hydroxymethyl prostaglandin E1. Prostaglandins (1985) 0.98
Prostacyclin for pulmonary hypertension. Lancet (1980) 0.98
The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review. J Clin Psychiatry (1995) 0.96
Treatment of hyperhomocysteinemia with folic acid and vitamins B12 and B6 attenuates thrombin generation. Thromb Res (1999) 0.96
Randomized trial comparing cryoablation and external beam radiotherapy for T2C-T3B prostate cancer. Prostate Cancer Prostatic Dis (2007) 0.96
Effect of verapamil on systolic and diastolic coronary blood flow velocity in asymptomatic and mildly symptomatic patients with hypertrophic cardiomyopathy. Heart (2000) 0.96
Profound overexpression of leukotriene C4 synthase in bronchial biopsies from aspirin-intolerant asthmatic patients. Int Arch Allergy Immunol (1997) 0.94
Sequence diversity of the MHC DRB gene in the Eurasian beaver (Castor fiber). Mol Ecol (2005) 0.94
Circulatory and anti-platelet effects of intravenous prostacyclin in healthy men. Pharmacol Res Commun (1978) 0.94
Hereditary hemorrhagic telangiectasia, factor V Leiden and antiphospholipid syndrome: a case report. Blood Coagul Fibrinolysis (2002) 0.94
The potential role of statins in contrast nephropathy. Clin Nephrol (2004) 0.93
Celecoxib in patients with asthma and aspirin intolerance. The Celecoxib in Aspirin-Intolerant Asthma Study Group. N Engl J Med (2001) 0.93
Contrasting patterns of variation in MHC loci in the Alpine newt. Mol Ecol (2008) 0.92
Comparison of the effect of verapamil and propranolol on response of coronary vasomotion to cold pressor test in symptomatic patients with hypertrophic cardiomyopathy. Cardiovasc Drugs Ther (2000) 0.92
Effect of inbreeding and heritability of sperm competition success in the bulb mite Rhizoglyphus robini. Heredity (Edinb) (2005) 0.92
Cardiopulmonary function in 1 -antitrypsin heterozygotes exposed to severe air pollution. Am Rev Respir Dis (1973) 0.92
Value of transthoracic echocardiography for the detection of high-grade coronary artery stenosis: prospective evaluation in 50 consecutive patients scheduled for coronary angiography. J Am Soc Echocardiogr (2000) 0.92
Dietary supplementation with vitamin E in hyperlipoproteinemias: effects on plasma lipid peroxides, antioxidant activity, prostacyclin generation and platelet aggregability. Thromb Haemost (1985) 0.92
Long-term survival of a urodele amphibian despite depleted major histocompatibility complex variation. Mol Ecol (2009) 0.92
Accuracy of allele frequency estimation using pooled RNA-Seq. Mol Ecol Resour (2013) 0.91
Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease. Prostaglandins (1986) 0.90
Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol (1997) 0.90
Immune biomarkers in relation to exposure to particulate matter: a cross-sectional survey in 17 cities of Central Europe. Inhal Toxicol (2000) 0.90
Mutations C677T and A1298C of the 5,10-methylenetetrahydrofolate reductase gene and fasting plasma homocysteine levels are not associated with the increased risk of venous thromboembolic disease. Blood Coagul Fibrinolysis (2002) 0.90
Heterogeneity of serum gamma-glutamyl transpeptidase in hepatobiliary diseases. Clin Chim Acta (1967) 0.90
Platelet glycoprotein IIIa polymorphism, aspirin, and thrombin generation. Lancet (1999) 0.89
A moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma. Clin Exp Allergy (2000) 0.89
Testing the status-dependent ESS model: population variation in fighter expression in the mite Sancassania berlesei. J Evol Biol (2004) 0.88
Sperm competition. Nature (1991) 0.88
Serum peptidases in myocardial infarction. Br Heart J (1972) 0.88
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA-DAHD database and the GALEN platform. The Galenda project. Allergy (2009) 0.88
Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis. Eur Respir J (2003) 0.86
Myocardial infarction in status asthmaticus. Lancet (1977) 0.86
The locus of sexual selection: moving sexual selection studies into the post-genomics era. J Evol Biol (2015) 0.86
Low density lipoproteins (LDL) are carriers for lipid peroxides and inhibit prostacyclin (PGI2) biosynthesis in arteries. Artery (1980) 0.86
The alpha-chain of high-affinity receptor for IgE (FcepsilonRIalpha) gene polymorphisms and serum IgE levels. Allergy (2006) 0.86
Immunological status of patients with recurrent chest infections. Lung (1978) 0.86
Anti-platelet action of intravenous infusion of prostacyclin in man. Thromb Res (1978) 0.86
Antiplatelet drugs and generation of thrombin in clotting blood. Blood (1992) 0.86
Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure. J Lab Clin Med (1980) 0.85
[Liver cirrhosis and dysimmunoglobulinemia in a patient with Pi M phenotype alpha 1-antitrypsin deficiency]. Pol Arch Med Wewn (1977) 0.85
Blood fibrinolytic activity, social class and habitual physical activity--II. A study of black and white men in Southern Georgia. J Chronic Dis (1980) 0.85
Thromboxane generation and platelet aggregation in survivals of myocardial infarction. Thromb Haemost (1978) 0.85
Pelvic fractures following irradiation of endometrial and vaginal cancers-a case series and review of literature. Radiother Oncol (2000) 0.85
Contrasting patterns of selection acting on MHC class I and class II DRB genes in the Alpine marmot (Marmota marmota). J Evol Biol (2012) 0.84
Prolonged bleeding time, reduced platelet aggregation, altered PAF-acether sensitivity and increased platelet mass are a trait of asthma and hay fever. Thromb Haemost (1986) 0.84
Asthma and anti-inflammatory drugs. Mechanisms and clinical patterns. Drugs (1983) 0.84
A time-motion study of the activities of attending physicians in an internal medicine and internal medicine-pediatrics resident continuity clinic. Acad Med (2000) 0.84
Aspirin-sensitive asthma: the effect of aspirin on the release of prostaglandins from nasal polyps. Pharmacol Res Commun (1977) 0.84
Exhaled eicosanoids following oral aspirin challenge in asthmatic patients. Clin Exp Allergy (2004) 0.84
Impaired response of the forearm resistance but not conductance vessels to reactive hyperemia in hypertrophic cardiomyopathy. Angiology (1999) 0.84
Serum lipoproteins, lipid peroxides and prostacyclin biosynthesis in patients with coronary heart disease. Prostaglandins (1981) 0.84